The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
An HTLV-I Vaccine: Why, How, for Whom?
Abstract
Endemic infection with the human T cell leukemia/lymphoma viruses I and II (HTLV-I/II) is now recognized to be worldwide, and is becoming epidemic among intravenous drug abusers (IVDAs) in the United States and Europe. The number of people around the world infected with HTLV-I can be estimated as between 10 and 20 million (Table 1). HTLV-I causes a rapidly progressing adult T cell leukemia/lymphoma (ATLL), and an incurable progressive neuromyelopathy named tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM), as well as a number of less well-studied syndromes. There is evidence that coinfection with HTLV-I or -II accelerates progression to AIDS. The cumulative lifetime risk of developing ATLL or TSP/HAM is around 5%, which, in terms of the induction of serious diseases, places HTLV-I in the same category of viruses for which efficient vaccines are made and used. Furthermore, there are factors favoring the feasibility of a vaccine against HTLV-I, in that the virus displays relatively low antigenic variability, natural immunity occurs in humans, and experimental vaccination with the envelope (Env) antigen is successful in animal models. A vaccine against HTLV-I would be of significant public health value in the fields of oncology, neurology, and AIDS, and it would serve as a pathfinder for a vaccine against HIV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
Self-citationNew use of BCG for recombinant vaccines
Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., et al. (1991) · Nature · doi:10.1038/351456a0 · Cited by 1,490
Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6981847 · Cited by 1,196
Okochi, K., Sato, H., & Hinuma, Y. (1984) · Vox Sanguinis · doi:10.1111/j.1423-0410.1984.tb00083.x · Cited by 663
Jacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S., & Koenig, S. (1990) · Nature · doi:10.1038/348245a0 · Cited by 613
Infective dermatitis of Jamaican children: a marker for HTLV-I infection
Blattner, W., LaGrenade, L., Hanchard, B., Fletcher, V., & Cranston, B. (1990) · The Lancet · doi:10.1016/0140-6736(90)92896-p · Cited by 453
High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans
Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., & Chen, I. S. Y. (1989) · Science · doi:10.1126/science.2655084 · Cited by 424
Murphy, E. L., Hanchard, B., Figueroa, J. P., Gibbs, W. N., Lofters, W. S., Campbell, M., Goedert, J. J., & Blattner, W. A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430214 · Cited by 404
Kaplan, J. E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., KHABBAZ, R. F., & Janssen, R. S. (1990) · PubMed · Cited by 369
Intrafamilial Transmission of Adult T Cell Leukemia Virus
Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., & Okochi, K. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.851 · Cited by 314
Tajima, K., The T‐ and B‐Cell Malignancy Study Group, & Co‐Authors (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450206 · Cited by 305
HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I
Mochizuki, M., Watanabe, T., Yamaguchi, K., Takatsuki, K., Yoshimura, K., Shirao, M., Nakashima, S., Mori, S., Araki, S., & Miyata, N. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb00092.x · Cited by 291
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Gessain, A., & Gout, O. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-11-933 · Cited by 205
Parker, C. E., Daenke, S., Nightingale, S., & Bangham, C. R. M. (1992) · Virology · doi:10.1016/0042-6822(92)90517-s · Cited by 201
Khabbaz, R. F., Onorato, I. M., Cannon, R. O., Hartley, T. M., Roberts, B., Hosein, B., & Kaplan, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260604 · Cited by 192
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama.
Lairmore, M. D., Jacobson, S., Gracia, F., De, B. K., Castillo, L., Larreategui, M., Roberts, B. D., Levine, P. H., Blattner, W. A., & Kaplan, J. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8840 · Cited by 182
Immunisation with canarypox virus expressing rabies glycoprotein
Cadoz, M., Meignier, B., Plotkin, S., Strady, A., Taylor, J., Tartaglia, J., & Paoletti, E. (1992) · The Lancet · doi:10.1016/0140-6736(92)92027-d · Cited by 182
Komurian, F., Pelloquin, F., & de Thé, G. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3770-3778.1991 · Cited by 160
Self-citationPseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.
Clapham, P. R., Nagy, K., & Weiss, R. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2886 · Cited by 155
Takahashi, K., Takezaki, T., Oki, T., Kawakami, K., Yashiki, S., Fujiyoshi, T., Usuku, K., THE MOTHER‐TO‐CHILD TRANSMISSION STUDY GROUP, Mueller, N., Osame, M., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490508 · Cited by 149
Ehrlich, G. D., Glaser, J. B., LaVigne, K., Quan, D., Mildvan, D., Sninsky, J. J., Kwok, S., Papsidero, L. D., & Poiesz, B. (1989) · Blood · doi:10.1182/blood.v74.5.1658.1658 · Cited by 145
Gessian, A., Yanagihara, R. T., Franchini, G., Garruto, R. M., Jenkins, C. L., Ajdukiewicz, A. B., Gallo, R. C., & Gajdusek, D. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7694 · Cited by 144
Multiple isolates and characteristics of human T-cell leukemia virus type II
Hall, W. W., Takahashi, H., Liu, C., Kaplan, M. H., Scheewind, O., Ijichi, S., Nagashima, K., & Gallo, R. C. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2456-2463.1992 · Cited by 143
Effect of the recombinant vaccinia viruses that express HTLV‐I envelope gene on HTLV‐I infection.
Shida, H., Tochikura, T. S., Sato, T., Konno, T., Hirayoshi, K., Seki, M., Itô, Y., Hatanaka, M., Hinuma, Y., & Sugimoto, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02660.x · Cited by 143
The epidemiology of HTLV-I infection
Mueller, N. E. (1991) · Cancer Causes & Control · doi:10.1007/bf00052359 · Cited by 141
PROGRESSION TO AIDS IN HOMOSEXUAL MEN CO-INFECTED WITH HIV AND HTLV-I IN TRINIDAD
Bartholomew, C., Blattner, W. A., & Cleghorn, F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91172-x · Cited by 141
Tanaka, Y., Zeng, L., Shiraki, H., Shida, H., & Tozawa, H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.354 · Cited by 137
HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users
Page, J. B., Lai, S., Chitwood, D. D., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)91456-k · Cited by 119
Nakamura, H., Hayami, M., Ohta, Y., Ishikawa, K., Tsujimoto, H., Kiyokawa, T., Yoshida, M., Sasagawa, A., & Honjo, S. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400320 · Cited by 101
Marciani, D. J., Kensil, C. R., Beltz, G. A., HUNG, C., Cronier, J., & AUBERT, A. (1991) · Vaccine · doi:10.1016/0264-410x(91)90262-5 · Cited by 95
Schulz, T. F., Calabrò, M. L., Hoad, J. G., Carrington, C. V. F., Matutes, E., Catovsky, D., & Weiss, R. A. (1991) · Virology · doi:10.1016/0042-6822(91)90418-b · Cited by 91
Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group
Meytes, D., Elgat, M., Schochat, B., Sidi, Y., Shaklai, M., Kilim, Y., Danon, Y. L., Nadel, G., Lee, H., Cerney, M., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)93308-c · Cited by 91
Palker, T. J., Riggs, E. R., Spragion, D., Muir, A. J., Scearce, R. M., Randall, R. R., McAdams, M. W., McKnight, Á., Clapham, P. R., & Weiss, R. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.5879-5889.1992 · Cited by 85
Sherman, M. P., Saksena, N. K., Dube, D. K., Yanagihara, R. T., & Poiesz, B. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2556-2563.1992 · Cited by 83
Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates
Gray, G. S., White, M. E., Bartman, T., & Mann, D. (1990) · Virology · doi:10.1016/0042-6822(90)90498-g · Cited by 79
Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits
Kataoka, R., Takehara, N., Iwahara, Y., Sawada, T., OHTSUKI, Y., Dawei, Y., Hoshino, H., & Miyoshi, I. (1990) · Blood · doi:10.1182/blood.v76.8.1657.bloodjournal7681657 · Cited by 78
Infectious transmission of human T‐cell leukemia virus to rabbits
Miyoshi, I., Yoshimoto, S., Kubonishi, I., Fujishita, M., Ohtsuki, Y., Yamashita, M., Yamato, K., Hirose, S., Taguchi, H., Niiya, K., et al. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350113 · Cited by 72
Sawada, T., Iwahara, Y., Ishii, K., Taguchi, H., Hoshino, H., & Miyoshi, I. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1193 · Cited by 58
Infection of rats with HTLV‐1: A small‐animal model for HTLV‐1 carriers
Suga, T., KAMEYAMA, T., Kinoshita, T., Shimotohno, K., Matsumura, M., Tanaka, H., Kushida, S., Ami, Y., Uchida, M., Uchida, K., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490522 · Cited by 56
High Prevalence of HTLV-II Among Intravenous Drug Abusers: PCR Confirmation and Typing
Kwok, S., Gallo, D., Hanson, C. V., McKinney, N., Poiesz, B. J., & Sninsky, J. J. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.561 · Cited by 53
Kuroki, M., Nakamura, M., Itoyama, Y., Tanaka, Y., Shiraki, H., Baba, E., Esaki, T., Tatsumoto, T., Nagafuchi, S., & Nakano, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.940 · Cited by 48
Hoshino, H., Miwa, M., Clapham, P. R., Weiss, R. A., Miyoshi, I., & Yoshida, M. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360609 · Cited by 38
Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus
Yamamoto, N., Hayami, M., Komuro, A., Schneider, J., Hunsmann, G., Okada, M., & Hinuma, Y. (1984) · Medical Microbiology and Immunology · doi:10.1007/bf02123570 · Cited by 32
Rose, C. (1991) · Trends in biotechnology · doi:10.1016/0167-7799(91)90142-5 · Cited by 17
Denic, S., Nolan, P., Doherty, J. D. H., Garson, J. A., Tuke, P. W., & Tedder, R. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)92619-s · Cited by 17
Infection of inbred rabbits with cell-free HTLV-I
Seto, A., Isono, T., & Ogawa, K. (1991) · Leukemia Research · doi:10.1016/0145-2126(91)90090-g · Cited by 16
Cited by
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Verdonck, K., González, E., Van Dooren, S., Vandamme, A.-M., Vanham, G., & Gotuzzo, E. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70081-6 · Cited by 661
Human T-lymphotropic virus type I infection
Manns, A., Hisada, M., & Grenade, L. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09460-4 · Cited by 360
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Ishitsuka, K., & Tamura, K. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70202-5 · Cited by 343
Yamano, Y., Nagai, M., Brennan, M., Mora, C. A., Soldan, S. S., Tomaru, U., Takenouchi, N., Izumo, S., Osame, M., & Jacobson, S. (2002) · Blood · doi:10.1182/blood.v99.1.88 · Cited by 279
Metadata
- Authors
- DE THÉ, G., & BOMFORD, R.
- Venue
- AIDS Research and Human Retroviruses
- Publisher
- SAGE Publications
- Published
- 1993-05
- Volume
- 9
- Issue
- 5
- Pages
- 381-386
- ISSN
- 0889-2229 (ISSN-L)
- 1931-8405
- OpenAlex
- W2030973107
- Cited by
- 272
- References
- 47
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.